Reduces
recurrence
31% to
15.4% (N- (7287 pts)) and
63.7% to 42.5% (N+ (1050
pts))
• 10 year gain
15,7% (N-)
and 21,2% (N+)
Reduces breast cancer
mortality
of 20.5% to 17.2%
(N-) and 51.3% to 42.8% (N+)
• 15 year gain
3.3% (N-) and
8.5% (N+)